These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 25075104)

  • 1. Case report: A breast cancer patient treated with GcMAF, sonodynamic therapy and hormone therapy.
    Inui T; Makita K; Miura H; Matsuda A; Kuchiike D; Kubo K; Mette M; Uto Y; Nishikata T; Hori H; Sakamoto N
    Anticancer Res; 2014 Aug; 34(8):4589-93. PubMed ID: 25075104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Case Report: A Non-small Cell Lung Cancer Patient Treated with GcMAF, Sonodynamic Therapy and Tumor Treating Fields.
    Inui T; Amitani H; Kubo K; Kuchiike D; Uto Y; Nishikata T; Mette M
    Anticancer Res; 2016 Jul; 36(7):3767-70. PubMed ID: 27354652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunotherapy of metastatic colorectal cancer with vitamin D-binding protein-derived macrophage-activating factor, GcMAF.
    Yamamoto N; Suyama H; Nakazato H; Yamamoto N; Koga Y
    Cancer Immunol Immunother; 2008 Jul; 57(7):1007-16. PubMed ID: 18058096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunotherapy of metastatic breast cancer patients with vitamin D-binding protein-derived macrophage activating factor (GcMAF).
    Yamamoto N; Suyama H; Yamamoto N; Ushijima N
    Int J Cancer; 2008 Jan; 122(2):461-7. PubMed ID: 17935130
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Case Report: GcMAF Treatment in a Patient with Multiple Sclerosis.
    Inui T; Katsuura G; Kubo K; Kuchiike D; Chenery L; Uto Y; Nishikata T; Mette M
    Anticancer Res; 2016 Jul; 36(7):3771-4. PubMed ID: 27354653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antitumor effect of vitamin D-binding protein-derived macrophage activating factor on Ehrlich ascites tumor-bearing mice.
    Koga Y; Naraparaju VR; Yamamoto N
    Proc Soc Exp Biol Med; 1999 Jan; 220(1):20-6. PubMed ID: 9893164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunotherapy of HIV-infected patients with Gc protein-derived macrophage activating factor (GcMAF).
    Yamamoto N; Ushijima N; Koga Y
    J Med Virol; 2009 Jan; 81(1):16-26. PubMed ID: 19031451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oleic Acid, deglycosylated vitamin D-binding protein, nitric oxide: a molecular triad made lethal to cancer.
    Ruggiero M; Ward E; Smith R; Branca JJ; Noakes D; Morucci G; Taubmann M; Thyer L; Pacini S
    Anticancer Res; 2014 Jul; 34(7):3569-78. PubMed ID: 24982371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral Colostrum Macrophage-activating Factor for Serious Infection and Chronic Fatigue Syndrome: Three Case Reports.
    Inui T; Kubo K; Kuchiike D; Uto Y; Nishikata T; Sakamoto N; Mette M
    Anticancer Res; 2015 Aug; 35(8):4545-9. PubMed ID: 26168499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunotherapy of BALB/c mice bearing Ehrlich ascites tumor with vitamin D-binding protein-derived macrophage activating factor.
    Yamamoto N; Naraparaju VR
    Cancer Res; 1997 Jun; 57(11):2187-92. PubMed ID: 9187119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of vitamin D(3)-binding protein-derived macrophage activating factor (GcMAF) on angiogenesis.
    Kanda S; Mochizuki Y; Miyata Y; Kanetake H; Yamamoto N
    J Natl Cancer Inst; 2002 Sep; 94(17):1311-9. PubMed ID: 12208896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical experience of integrative cancer immunotherapy with GcMAF.
    Inui T; Kuchiike D; Kubo K; Mette M; Uto Y; Hori H; Sakamoto N
    Anticancer Res; 2013 Jul; 33(7):2917-9. PubMed ID: 23780980
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inconsistencies and questionable reliability of the publication "immunotherapy of metastatic colorectal cancer with vitamin D-binding protein-derived macrophages-activating, GcMAF" by Yamamoto et al.
    Ugarte A; Bouche G; Meheus L
    Cancer Immunol Immunother; 2014 Dec; 63(12):1347-8. PubMed ID: 25056820
    [No Abstract]   [Full Text] [Related]  

  • 14. Degalactosylated/desialylated human serum containing GcMAF induces macrophage phagocytic activity and in vivo antitumor activity.
    Kuchiike D; Uto Y; Mukai H; Ishiyama N; Abe C; Tanaka D; Kawai T; Kubo K; Mette M; Inui T; Endo Y; Hori H
    Anticancer Res; 2013 Jul; 33(7):2881-5. PubMed ID: 23780974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gc protein-derived macrophage activating factor (GcMAF): isoelectric focusing pattern and tumoricidal activity.
    Mohamad SB; Nagasawa H; Sasaki H; Uto Y; Nakagawa Y; Kawashima K; Hori H
    Anticancer Res; 2003; 23(6a):4451-7. PubMed ID: 14666733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunotherapy with GcMAF revisited - A critical overview of the research of Nobuto Yamamoto.
    Albracht SP
    Cancer Treat Res Commun; 2022; 31():100537. PubMed ID: 35217488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sonodynamic and photodynamic therapy in advanced breast carcinoma: a report of 3 cases.
    Wang X; Zhang W; Xu Z; Luo Y; Mitchell D; Moss RW
    Integr Cancer Ther; 2009 Sep; 8(3):283-7. PubMed ID: 19815599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination sonodynamic therapy with immunoadjuvant may be a promising new modality for cancer treatment.
    Ma X; Pan H; Yi J
    Med Hypotheses; 2009 Apr; 72(4):418-20. PubMed ID: 19128891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation of Gc protein-derived macrophage activating factor (GcMAF) and its structural characterization and biological activities.
    Mohamad SB; Nagasawa H; Uto Y; Hori H
    Anticancer Res; 2002; 22(6C):4297-300. PubMed ID: 12553073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted chemo-sonodynamic therapy treatment of breast tumours using ultrasound responsive microbubbles loaded with paclitaxel, doxorubicin and Rose Bengal.
    Logan K; Foglietta F; Nesbitt H; Sheng Y; McKaig T; Kamila S; Gao J; Nomikou N; Callan B; McHale AP; Callan JF
    Eur J Pharm Biopharm; 2019 Jun; 139():224-231. PubMed ID: 30959180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.